List of Alcresta Therapeutics patents

Patent 9668942 was granted and assigned to Alcresta Therapeutics on June, 2017 by the United States Patent and Trademark Office.

Patent 11045396 was granted and assigned to Alcresta Therapeutics on June, 2021 by the United States Patent and Trademark Office.

Patent 11291236 was granted and assigned to Alcresta Therapeutics on April, 2022 by the United States Patent and Trademark Office.

Patent 10258590 was granted and assigned to Alcresta Therapeutics on April, 2019 by the United States Patent and Trademark Office.

Patent 11045440 was granted and assigned to Alcresta Therapeutics on June, 2021 by the United States Patent and Trademark Office.

Patent 9775783 was granted and assigned to Alcresta Therapeutics on October, 2017 by the United States Patent and Trademark Office.

Patent 9775784 was granted and assigned to Alcresta Therapeutics on October, 2017 by the United States Patent and Trademark Office.

Patent 9687420 was granted and assigned to Alcresta Therapeutics on June, 2017 by the United States Patent and Trademark Office.

Patent 10828239 was granted and assigned to Alcresta Therapeutics on November, 2020 by the United States Patent and Trademark Office.

Patent 10987280 was granted and assigned to Alcresta Therapeutics on April, 2021 by the United States Patent and Trademark Office.